Vabysmo is a bispecific antibody designed to inhibit vascular endothelial growth factor (VEGF) and angiopoietin-2 (Ang-2).

STAT6 degradation is expected to provide a clinical benefit for patients with Type 2 inflammatory diseases, including asthma.

The authors updated a diagnosis list to identify low-acuity emergency department visits by veterans and applied it to examine ...

The majority of deafness cases throughout the world are genetic in origin, and for years, scientists have been exploring ways that gene therapies could make deafness a thing of the past. By delivering ...

Get personalized, AI-powered answers built on 27+ years of trusted expertise. "Affluent," according to Visa Inc. (V), means being the top 10%. According to the company's November 2025 report, the top ...

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...